GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medidata Solutions Inc (NAS:MDSO) » Definitions » 5-Year RORE %

Medidata Solutions (Medidata Solutions) 5-Year RORE % : 0.00% (As of Jun. 2019)


View and export this data going back to 2009. Start your Free Trial

What is Medidata Solutions 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Medidata Solutions's 5-Year RORE % for the quarter that ended in Jun. 2019 was 0.00%.

The industry rank for Medidata Solutions's 5-Year RORE % or its related term are showing as below:

MDSO's 5-Year RORE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 4.465
* Ranked among companies with meaningful 5-Year RORE % only.

Medidata Solutions 5-Year RORE % Historical Data

The historical data trend for Medidata Solutions's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medidata Solutions 5-Year RORE % Chart

Medidata Solutions Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medidata Solutions Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medidata Solutions's 5-Year RORE %

For the Health Information Services subindustry, Medidata Solutions's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medidata Solutions's 5-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medidata Solutions's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Medidata Solutions's 5-Year RORE % falls into.



Medidata Solutions 5-Year RORE % Calculation

Medidata Solutions's 5-Year RORE % for the quarter that ended in Jun. 2019 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 0.71-0.136 )/( 2.746-0 )
=0.574/2.746
=20.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2019 and 5-year before.


Medidata Solutions  (NAS:MDSO) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Medidata Solutions 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Medidata Solutions's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medidata Solutions (Medidata Solutions) Business Description

Traded in Other Exchanges
N/A
Address
350 Hudson Street, 9th Floor, New York, NY, USA, 10014
Medidata Solutions Inc provides cloud-based solutions for the clinical development programs of life sciences companies. Its customers include biopharmaceutical companies, device makers, contract research organizations, and academic institutions. The majority of the company's business comes from subscriptions to the Medidata Clinical Cloud, with the remainder of revenue coming from services. The Medidata Clinical Cloud provides solutions for study design and planning, data capture, patient activity measurement, risk-based monitoring, and payments. The services segment includes technology and support services and professional consulting services. The majority of the firm's revenue is generated within the United States.
Executives
Carlos Dominguez director C/O MEDIDATA SOLUTIONS, INC., 79 FIFTH AVENUE, 8TH FLOOR, NEW YORK NY 10003
Lee Shapiro director C/O ALLSCRIPTS HEALTCHARE SOLUTIONS, 2401 COMMERCE DR, LIBERTYVILLE IL 60048
Michael L Capone officer: Chief Operating Officer C/O DYNATRACE HOLDINGS LLC, 1601 TRAPELO ROAD, SUITE 116, WALTHAM MA 02451
Eileen Schloss officer: OUTGOING EVP, HUMAN RESOURCES C/O MEDIDATA SOLUTIONS, INC., 79 FIFTH AVENUE, 8TH FLOOR, NEW YORK NY 10003
Alan Mateo officer: EVP, Field Operations C/O VEEVA SYSTEMS, 4280 HACIENDA DRIVE, PLEASANTON CA 94588
Insight Holdings Group, Llc 10 percent owner 1114 AVENUE OF THE AMERICAS, 36TH FLOOR, NEW YORK NY 10036

Medidata Solutions (Medidata Solutions) Headlines

From GuruFocus

Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,000 Shares

By GuruFocus Research GuruFocus Editor 03-03-2011

Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 13,667 Shares

By GuruFocus Research GuruFocus Editor 02-08-2011

There's More In The Clouds At Medidata Than Just The Valuation

By Ken McGaha Ken McGaha 07-21-2015

Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,667 Shares

By GuruFocus Research GuruFocus Editor 03-08-2011